Neogenex

Neogenex — FDA 510(k) Submissions

Neogenex has submitted 20 FDA 510(k) premarket notifications since 1994, of which 20 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Cells, Animal And Human, Cultured, Antisera, Cf, Influenza Virus A, B, C, Respiratory Syncytial Virus, Antigen, Antibody, Ifa, Antiserum, Fluorescent, Chlamydia Trachomatis, Antiserum, Cf, Cytomegalovirus . Use the specialty filter in the sidebar to narrow results.